Recruiting studies: Biochemical Recurrence Of Malignant Neoplasm Of Prostate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Phase 2 · 11 location(s) · Swiss Cancer Institute · NCT07365423 Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT05588128 Artificial Intelligence-based Platform, Integrating Pathologic, Imaging and Molecular Profiles of Prostate Cancer
Phase N/A · 1 location(s) · Azienda Ospedaliero Universitaria Maggiore della Carita · NCT06468332 PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT05022914 An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT06813898 Alpha Radiation Emitters Device (DaRT) for the Treatment of Non-Metastatic Locally Recurrent Prostate Cancer.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT06202248 A Prospective, Bicentric Evaluation of Fluciclovine PET-imaging in Patients with Prior Negative or Inconclusive PSMA-lig
Phase N/A · 2 location(s) · Technical University of Munich · NCT06859203 Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20
NA · 4 location(s) · CHU de Quebec-Universite Laval · NCT07483658 Diagnostic Performance of [18F]PSMA-1007 in the Context of Biochemical Recurrence of Prostate Cancer
Phase N/A · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06657131 PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Phase 2 · 1 location(s) · Hoag Memorial Hospital Presbyterian · NCT04700332 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients
Phase 3 · 8 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT05847348 PROCARE - PROstate Cancer Real World Evidence Registry
Phase N/A · 53 location(s) · UroTrials Company (GmbH) · NCT06835218

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.